CRS: JHU
Position: Co-investigator
CRS: BJMC
Position: Dean, BJ Medical College and India CRS PI
Position: Study Coordinator
Position: CRS Leader
Position: CTU Leader for HPTN Studies
Position: Site Leader
Position: Global Community Advisory Board Representative
CRS: BJMCJHU
Position: Principal Investigator, Johns Hopkins Professor of Medicine and Public Health; Deputy Director, CCGHE
Position: CRS Data Manager and Deputy Director
The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...
An estimated 3 million HIV-infected individuals will enter programs for antiretroviral (ARV) treatment in the coming year, with...
1077BF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
Rifampin (RIF), the cornerstone of TB treatment, has very problematic drug-drug interactions with PIs. The use of relatively...
